This study is designed to provide a comprehensive overview of evidence concerning the efficacy and safety of dexamethasone phonophoresis and laser acupuncture for treatment of chronic rhinosinusitis.

Inclusion Criteria:

• Age range between 30 to 50 years.
• Male and female patients will participate in the study.
• All patients have chronic rhinosinusitis, who are experiencing 12 weeks or longer of 2 or more of the following signs and symptoms:

mucopurulent drainage (anterior, posterior, or both) nasal obstruction (congestion) facial pain-pressure-fullness, or decreased sense of smell

• All patients enrolled in the study will have their informed consent.

Exclusion Criteria:

• Patients with metal implants (pacemakers, dental implants, or any other implants).
• Patients with cancer, pregnancy or impaired vascular circulation.
• Patients who suffer from mental or psychological disorders.
• Patients with any systemic diseases that may interfere with the objectives of the study.
• Patients with long-term use of corticosteroids or immunosuppressive agents.
• Congenital defects on face and nose.
• Fracture of nose or face.
• Patients who are contraindicated for corticosteroids use in patient who will receive dexamethasone phonophoresis.
• Allergic patients.
• Pervious nasal surgery.
• Patients with nasal septum deviation.
• patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks or any medication that may interfere with the objectives of the study.

pre and post assessment measures results of:

1. Sino nasal Outcome Test 22 (SNOT-22)
2. Computerized Tomography Scan: